Colorectal carcinoma infiltration by myeloperoxidase-expressing neutrophil granulocytes is associated with favorable prognosis

OncoImmunology

Volumn 2, Issue 10, 2013, Pages

  Hirt, Christian ^a,b   Eppenberger Castori, Serenella ^c   Sconocchia, Giuseppe ^d   Iezzi, Giandomenica ^b   Tornillo, Luigi ^c   Terracciano, Luigi ^c   Spagnoli, Giulio C ^b   Droeser, Raoul A ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

Author keywords

CD15; Human colorectal cancer; Mismatch repair status; Myeloperoxidase; Prognosis; Tissue microarray

Indexed keywords

CD15 ANTIGEN; CYTOKINE; MONOCLONAL ANTIBODY; MYELOPEROXIDASE;

ARTICLE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL INFILTRATION; COHORT ANALYSIS; COLORECTAL CARCINOMA; GRANULOCYTE; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LYMPH NODE METASTASIS; NATURAL KILLER CELL; NEUTROPHIL; ONCOLOGICAL PARAMETERS; TUMOR IMMUNITY;

EID: 84890281390     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.25990     Document Type: Article

References (10)

1. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960- 4; PMID:17008531; http://dx.doi.org/10.1126/ science.1129139
2. Sconocchia G, Arriga R, Tornillo L, Terracciano L, Ferrone S, Spagnoli GC. Melanoma cells inhibit NK cell functions. Cancer Res 2012; 72:5428-9, author reply 5430; PMID:23047870; http://dx.doi. org/10.1158/0008-5472.CAN-12-1181
3. Sconocchia G, Zlobec I, Lugli A, Calabrese D, Iezzi G, Karamitopoulou E, Patsouris ES, Peros G, Horcic M, Tornillo L, et al. Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma. Int J Cancer 2011; 128:2663-72; PMID:20715106; http://dx.doi.org/10.1002/ijc.25609
4. Moulding DA, Hart CA, Edwards SW. Regulation of neutrophil FcgammaRIIIb (CD16) surface expression following delayed apoptosis in response to GM-CSF and sodium butyrate. J Leukoc Biol 1999; 65:875-82; PMID:10380913
5. Droeser RA, Hirt C, Eppenberger-Castori S, Zlobec I, Viehl CT, Frey DM, Nebiker CA, Rosso R, Zuber M, Amicarella F, et al. High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS One 2013; 8:e64814; PMID:23734221; http://dx.doi. org/10.1371/journal.pone.0064814
6. Rao H-L, Chen J-W, Li M, Xiao Y-B, Fu J, Zeng Y-X, Cai M-Y, Xie D. Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis. PLoS One 2012; 7:e30806; PMID:22295111; http://dx.doi.org/10.1371/journal.pone.0030806
7. Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011; 11:519-31; PMID:21785456; http://dx.doi. org/10.1038/nri3024
8. Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, Gehling UM, Brümmer J, Rudolph V, Münzel T, Heitzer T, et al. Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins. Proc Natl Acad Sci U S A 2005; 102:431- 6; PMID:15625114; http://dx.doi.org/10.1073/ pnas.0405193102
9. Valerius T, Repp R, de Wit TP, Berthold S, Platzer E, Kalden JR, Gramatzki M, van de Winkel JG. Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colonystimulating factor therapy. Blood 1993; 82:931-9; PMID:7687898
10. De Larco JE, Wuertz BRK, Furcht LT. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 2004; 10:4895-900; PMID:15297389; http://dx.doi.org/10.1158/1078-0432.CCR-03-0760